Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome ...

H.C. Wainwright raised the firm’s price target on Soleno Therapeutics (SLNO) to $100 from $70 and keeps a Buy rating on the shares after the ...

Mum-of-five Katie Price isn’t spending Mother’s Day with her children this year—but there’s a reason. The reality TV star, 46 ...

The Twins are currently likely to give most of the playing time at second base to Castro, Dan Hayes of The Athletic reports. As Hays notes, there's a decent chance the defensively versatile Castro ...

sources say 4:55 AM UTC Healthcare & Pharmaceuticalscategory US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome March 26, 2025 Healthcare & Pharmaceuticalscategory US ...

In 2023 Willi Castro was a really good player, playing mostly third, left and center. Not great in center field, but pretty good in left and third. I think he's decent at second, third and left ...